Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL703124 | 0.89 | CNR1 (0.58) | CNR1CNR2 | |
| SCHEMBL702010 | 0.87 | CNR1 (0.59) | CNR1CNR2 | |
| SCHEMBL3177198 | 0.84 | CNR1 (0.52) | CNR1CNR2 | |
| SCHEMBL702914 | 0.82 | CNR1 (0.70) | CNR1CNR2 | |
| SCHEMBL702556 | 0.80 | CNR1 (0.69) | CNR1CNR2 | |
| SCHEMBL701648 | 0.80 | CNR1 (0.65) | CNR1CNR2 | |
| SCHEMBL702479 | 0.80 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL702755 | 0.79 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL3168055 | 0.79 | CNR1 (0.49) | CNR1CNR2 | |
| SCHEMBL700775 | 0.78 | CNR1 (0.65) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121617-B1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA AS (DK) | 2014-01-22 | — | — | EP | claimed |
| US-8124634-B2 | CB1 receptor modulators | 7TM PHARMA A/S (DK) | 2012-02-28 | — | — | US | claimed |
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2010-01-14 | — | — | US | claimed |
| EP-2121617-A1 | CB1 RECEPTOR MODULATORS | 7TM Pharma A/S (DK) | 2009-11-25 | — | — | EP | claimed |
| WO-2008075012-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2008-06-26 | — | — | WO | claimed |
| EP-2121617-B1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA AS (DK) | 2014-01-22 | — | — | EP | disclosed |
| US-8124634-B2 | CB1 receptor modulators | 7TM PHARMA A/S (DK) | 2012-02-28 | — | — | US | disclosed |
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | CNR1, CNR2, GPR6 | CNR1 1/4885CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.